Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
66.50
0.63 (0.96%)
At close: May 12, 2025, 3:59 PM
66.60
0.15%
After-hours: May 12, 2025, 05:15 PM EDT
Halozyme Therapeutics Revenue
Halozyme Therapeutics reported an annual revenue of $1.02B, reflecting a 22.44% growth. For the quarter ending December 31, 2024, Halozyme Therapeutics generated $298.01M in revenue.
Revenue (ttm)
$1.02B
Revenue Growth
22.44%
Price / Sales Ratio
5.97
Revenue / Employee
$2.9M
Employees
350
Market Cap
8.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|